Selena Koch
Executive editor at BioCentury who covers clinical development and therapeutic areas such as psychedelics and obesity drugs, providing analysis of trial readouts and catalysts.
Best podcasts with Selena Koch
Ranked by the Snipd community
14 snips
Aug 19, 2025 • 29min
Ep. 316 - Trends in Pharma Deals
Lauren Martz, Executive Director of Biopharma Intelligence, leads a discussion on the latest trends in pharmaceutical deals, revealing that bispecifics and degraders are gaining traction while cell and gene therapies are losing favor. Selena Koch, Executive Editor, shares insights from a recent conversation with Denali about advancements in brain shuttles. Karen Koch-Tusman highlights a groundbreaking FDA approval for a vector-based immunotherapy, suggesting potential new standards for treating rare diseases. Chinese biotech's growing influence is also addressed.
11 snips
Feb 3, 2026 • 31min
Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules
Simone Fishburn, geopolitics and life‑sciences policy commentator; Selena Koch, editorial strategist on industry trends; Steve Usdin, policy and regulatory analyst; Lauren Martz, biopharma intelligence lead on RNA and renal. They unpack RNAi and antisense as 2026 catalysts. They cover cardiovascular Lp(a) trials, renal and neuromuscular readouts, obesity launches, and China’s new orphan drug exclusivity rule.
